Browsing by Author "Gichangi, P."

Now showing items 1-4 of 4

    • Accept ability of human immunodeficiency virustesting in patients with invasivecervical cancer in Kenya 

      Gichangi, P.; Bwayoy, J.; Rogoz, K.; Ojwang, S.; Njuguna, E.; Temmermank, M.; Estambale, Benson B. (Int J Gynecol Cancer, 2006)
      Invasive cervical cancer (ICC) is common in areas where human immunodeficiency virus (HIV) is also prevalent. Currently, HIV seroprevalence as well as acceptability of HIV testing in ICC patients in Kenya is unknown. The ...

    • HIV and cervical cancer in Kenya 

      Gichangi, P.; Vuyst, H. De; Estambale, Benson B.; Rogo, K.; Bwayo, J.; Temmerman, M. (International Journal of Gynecology & Obstetrics, 2002-01-22)
      To determine the effect of the HIV epidemic on invasive cervical cancer in Kenya. Methods: Of the 3902 women who were diagnosed with reproductive tract malignancies at Kenyatta National Hospital (KNH) from 1989 to 1998, ...

    • HIV and cervical cancer in Kenya 

      Gichangi, P.; De Vuyst, H.; Estambale, Benson B.; Rogo, K.; Bwayo, J.; Temmerman, M. (International Journal of Gynecology and Obstetrics, 2002-01)
      Objectives: To determine the effect of the HIV epidemic on invasive cervical cancer in Kenya. Methods: Of the 3902 women who were diagnosed with reproductive tract malignancies at Kenyatta National Hospital (KNH) from 1989 ...

    • Knowledge and practice about cervical cancer and pap smear testing among patients at Kenyatta National Hospital, Nairobi, Kenya 

      Gichangi, P.; Estambale, Benson B.; Bwayo, J.; Rogo, K.; Ojwang, S.; Opiyo, A.; Temmerman, M. (International Journal of Gynecological Cancer, 2003-11)
      Invasive cervical cancer (ICC) is the leading cause of cancer-related death among women in developing countries. Population-based cyto-logic screening and early treatment does reduce morbidity and mortality associated with ...